21 – 30 of 45
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2020
-
Mark
Proteomic exploration of common pathophysiological pathways in diabetes and cardiovascular disease
2020) In ESC Heart Failure(
- Contribution to journal › Article
-
Mark
Metabolically Healthy Obesity (MHO)-New Research Directions for Personalised Medicine in Cardiovascular Prevention
(
- Contribution to journal › Scientific review
-
Mark
A diabetes-associated genetic variant is associated with diastolic dysfunction and cardiovascular disease
(
- Contribution to journal › Article
- 2019
-
Mark
Skin autofluorescence as a measure of advanced glycation end product levels is associated with carotid atherosclerotic plaque burden in an elderly population
(
- Contribution to journal › Article
-
Mark
Metabolically healthy obesity (MHO) in the Malmö diet cancer study - Epidemiology and prospective risks
(
- Contribution to journal › Article
-
Mark
Selenoprotein P Deficiency and Risk of Mortality and Rehospitalization in Acute Heart Failure
(
- Contribution to journal › Letter
-
Mark
Echocardiographic Findings in Patients with Mild to Moderate Chronic Kidney Disease without Symptomatic Heart Failure : A Population-Based Study
(
- Contribution to journal › Article
-
Mark
Using a Targeted Proteomics Chip to Explore Pathophysiological Pathways for Incident Diabetes- The Malmö Preventive Project
(
- Contribution to journal › Article
-
Mark
Heart failure and metabolic factors
2019) p.123-133(
- Chapter in Book/Report/Conference proceeding › Book chapter
- 2017
-
Mark
Single and multiple cardiovascular biomarkers in subjects without a previous cardiovascular event
(
- Contribution to journal › Article